Mupirocin is not a steroid. It is a topical antibiotic, meaning it kills bacteria on the skin rather than reducing inflammation the way a steroid would. This is one of the most common points of confusion about the medication, likely because mupirocin ointment looks and feels similar to topical steroid creams and is sometimes prescribed for the same areas of the body.
How Mupirocin Actually Works
Mupirocin fights bacterial infections by blocking a specific step in how bacteria build proteins. Without functional proteins, the bacteria can’t grow or survive, and the infection clears. This mechanism is completely different from how steroids work. Topical steroids suppress your immune system locally and reduce swelling, redness, and itching. They have no ability to kill bacteria. Mupirocin has no ability to reduce inflammation.
That distinction matters for practical reasons. If you have a bacterial skin infection like impetigo or an infected wound, a steroid cream could actually make things worse by dialing down the immune response your body needs to fight the bacteria. Mupirocin targets the infection directly. On the flip side, if your skin problem is purely inflammatory (eczema, for example), mupirocin won’t help because there’s no bacterial infection to treat.
What Mupirocin Treats
Mupirocin is the most widely used topical antibiotic in the world for treating MRSA, a type of staph bacteria that resists many other antibiotics. It’s particularly effective against skin infections caused by staphylococci and streptococci, the two bacterial families behind most common skin infections. Impetigo, the crusty, spreading skin infection common in children, is one of its primary uses.
Beyond treating active infections, mupirocin has a second important role: clearing MRSA from the nose. Many people carry MRSA bacteria in their nostrils without symptoms, but this colonization raises the risk of serious infections, especially in hospitals. The standard protocol involves applying a small amount of mupirocin inside each nostril twice daily for five days. This nasal decolonization is routine for hospital patients with medical devices who are known MRSA carriers.
Why People Confuse It With Steroids
Several things feed this confusion. Both mupirocin and topical steroids come as ointments or creams in similar-looking tubes. Both are applied directly to the skin. And doctors sometimes prescribe them for overlapping conditions. A red, irritated patch of skin might get a steroid if the problem is eczema, or mupirocin if the problem is a bacterial infection, or occasionally both if an eczema flare has become secondarily infected.
The confusion also comes from the fact that people often don’t know what drug class their prescription belongs to. If you’ve been handed a tube of mupirocin and weren’t told much about it, it’s reasonable to wonder whether it carries the same risks as steroid creams, like skin thinning with prolonged use. It doesn’t. Mupirocin does not cause the skin atrophy, stretch marks, or hormonal effects associated with long-term topical steroid use. Its side effects are generally limited to local skin irritation at the application site.
How It Compares to Topical Steroids
- Drug class: Mupirocin is an antibiotic. Topical steroids (like hydrocortisone, betamethasone, or triamcinolone) are anti-inflammatory corticosteroids.
- Purpose: Mupirocin kills bacteria. Steroids reduce inflammation, redness, and itching.
- Skin thinning risk: Topical steroids can thin the skin with prolonged use. Mupirocin does not carry this risk.
- Typical duration: Mupirocin is generally used for short courses, often 5 to 10 days. Some topical steroids are also used short-term, but others are prescribed for longer periods in chronic conditions.
- Effect on infections: Mupirocin treats bacterial infections. Steroids can mask or worsen infections by suppressing local immune function.
Resistance Is a Growing Concern
Because mupirocin is an antibiotic, bacteria can develop resistance to it over time. CDC data from 2005 to 2022, based on over 11,000 MRSA samples, shows that high-level mupirocin resistance in MRSA increased from under 1% to about 5.4% between 2005 and 2013. Since then, it has plateaued in the range of 2.6% to 6.1% with no significant upward trend. These numbers are still relatively low, but they’re one reason mupirocin is typically prescribed for short, defined courses rather than open-ended use. Using it longer than directed or for conditions it wasn’t prescribed for contributes to resistance developing.
This is another key difference from steroids. You don’t develop “resistance” to a steroid cream the way bacteria develop resistance to an antibiotic. The concerns with each medication are fundamentally different because the medications do fundamentally different things.